NAGE Competitors & Alternatives
Compare Niagen Bioscience, Inc. with similar stocks in the same industry
Biotechnology
NAGE
Main Stock$3.22
Tradestie Score
42
Market Cap
$629.25M
P/E Ratio
16.6
Revenue Growth
0.0%
Analyst Upside
+275.3%
Top Competitors
240 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DBVT
DBV Technologies S.A.
|
$14.22
|
$275.54M | - | 47 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.05
|
$275.13M | - | 47 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$22.78
|
$269.08M | 0.1 | 44 | Compare |
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$6.29
|
$262.67M | - | 43 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$8.27
|
$258.18M | - | 36 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$39.85
|
$256.54M | - | 38 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$13.45
|
$240.89M | - | 38 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.61
|
$231.77M | - | 31 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$10.23
|
$227.00M | - | 33 | Compare |
More NAGE Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2833)
240 stocks in this industry